InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Weisblum Eric, Chief Executive Officer. Officer active across 1 companies, notably Silo Pharma, Inc.. Aggregated, 7 filings have been logged. Total volume traded: €3k. The latest transaction was filed on 17 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
€1,42213,080 shares@ €0.10880.022% mcap47.4% of flow
Common Stock
SEC:0001213900-22-033752:0·
Ideal exit: 14 Mar 2023 (T+270)
€6885,000 shares@ €0.137687.0% of flow
Common Stock
SEC:0001213900-21-065395·
Ideal exit: 6 Sept 2022 (T+270)
€6885,000 shares@ €0.13760.011% mcap22.9% of flow
Common Stock
SEC:0001213900-21-065395:0·
Ideal exit: 6 Sept 2022 (T+270)
7,630,949 shares
Common Stock
SEC:0001213900-21-026677·
€10357,714 shares@ €0.001813.0% of flow
Common Stock
SEC:0001213900-21-026675·
Ideal exit: 13 Mar 2020 (T+270)
€10357,714 shares@ €0.00180.0016% mcap3.4% of flow
Common Stock
SEC:0001213900-21-026675:0·
Ideal exit: 13 Mar 2020 (T+270)
7,630,949 shares
Common Stock
SEC:0001213900-21-026677:0·
7 of 7 declarations
About Weisblum Eric
Eric Weisblum serves as the Chief Executive Officer, Chief Financial Officer, and President of Silo Pharma, Inc. He oversees the company's operations and is responsible for financial management. His leadership is essential for the success of the organization.
